English
简体中文
Total: £ 56.28
Published Date: 2025-11-27 | Pages: 96 | Tables: 95 | Medical Devices & Consumables
The global market for Immortalized Human Cells was valued at US$ 1500 million in the year 2024 and is projected to reach a revised size of US$ 3080 million by 2031, growing at a CAGR of 11.8% during the forecast period.
The global volume of technical services related to immortalized human cells reached approximately 3.72 million projects in 2024, with an average customer price of $403.15 per project. Immortalized human cells are human cell lines with unlimited proliferative capacity obtained through genetic engineering techniques. Related technical services include cell line establishment, gene editing, functional validation, drug screening, and customized culture. These services provide crucial technology platforms and solutions for drug development, disease modeling, and biomedical research, significantly enhancing research efficiency and reliability.
The technical service market for immortalized human cells is currently in a critical phase of rapid professionalization and standardization. The market's current state is characterized by growing demand for regulatory-compliant standardized cell line establishment, complex gene editing, and high-quality functional validation services, driven by the needs of precision medicine and personalized therapies. Professional CRO companies and large biotechnology firms dominate the market by establishing standardized technology platforms and quality systems. The development trend is clearly directed towards higher throughput and more precise technical services, including the integration of innovative services such as automated screening platforms, multi-omics analysis integration, and AI-assisted cell phenotype analysis. The prevailing market view is that future competition will extend beyond basic technical services to focus more on the capability to provide integrated solutions, data quality and depth of analytical value, and the completeness of technical systems meeting stringent regulatory requirements. Meanwhile, balancing service standardization with personalized needs will become a significant challenge for enterprises.
This report aims to provide a comprehensive presentation of the global market for Immortalized Human Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immortalized Human Cells.
The Immortalized Human Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immortalized Human Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, by Source and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immortalized Human Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ispecimen
ABO Bio
AnaBios
Biomedica Cro
Bioivt
Iprocess
Crown Bioscience
Biomex
PrecisionMed
Cureline
DX Biosamples
Audubon
Precision for Medicine
Discovery Life Sciences
ProteoGenex
CGT Global
Segment by Type
Ready-to-use
Customized
Segment by Source
Liver-Derived
Kidney-Derived
Nervous System-Derived
Other
Segment by Identity
Identified Samples
Anonymized Samples
Segment by Application
Medical Research
Vaccine Development
Gene Therapy
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Source etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immortalized Human Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immortalized Human Cells Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ready-to-use
1.2.3 Customized
1.3 Market by Source
1.3.1 Global Immortalized Human Cells Market Size Growth Rate by Source: 2020 VS 2024 VS 2031
1.3.2 Liver-Derived
1.3.3 Kidney-Derived
1.3.4 Nervous System-Derived
1.3.5 Other
1.4 Market by Identity
1.4.1 Global Immortalized Human Cells Market Size Growth Rate by Identity: 2020 VS 2024 VS 2031
1.4.2 Identified Samples
1.4.3 Anonymized Samples
1.5 Market by Application
1.5.1 Global Immortalized Human Cells Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Medical Research
1.5.3 Vaccine Development
1.5.4 Gene Therapy
1.5.5 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Immortalized Human Cells Market Perspective (2020-2031)
2.2 Global Immortalized Human Cells Growth Trends by Region
2.2.1 Global Immortalized Human Cells Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Immortalized Human Cells Historic Market Size by Region (2020-2025)
2.2.3 Immortalized Human Cells Forecasted Market Size by Region (2026-2031)
2.3 Immortalized Human Cells Market Dynamics
2.3.1 Immortalized Human Cells Industry Trends
2.3.2 Immortalized Human Cells Market Drivers
2.3.3 Immortalized Human Cells Market Challenges
2.3.4 Immortalized Human Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immortalized Human Cells Players by Revenue
3.1.1 Global Top Immortalized Human Cells Players by Revenue (2020-2025)
3.1.2 Global Immortalized Human Cells Revenue Market Share by Players (2020-2025)
3.2 Global Top Immortalized Human Cells Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Immortalized Human Cells Revenue
3.4 Global Immortalized Human Cells Market Concentration Ratio
3.4.1 Global Immortalized Human Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immortalized Human Cells Revenue in 2024
3.5 Global Key Players of Immortalized Human Cells Head office and Area Served
3.6 Global Key Players of Immortalized Human Cells, Product and Application
3.7 Global Key Players of Immortalized Human Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immortalized Human Cells Breakdown Data by Type
4.1 Global Immortalized Human Cells Historic Market Size by Type (2020-2025)
4.2 Global Immortalized Human Cells Forecasted Market Size by Type (2026-2031)
5 Immortalized Human Cells Breakdown Data by Application
5.1 Global Immortalized Human Cells Historic Market Size by Application (2020-2025)
5.2 Global Immortalized Human Cells Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Immortalized Human Cells Market Size (2020-2031)
6.2 North America Immortalized Human Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Immortalized Human Cells Market Size by Country (2020-2025)
6.4 North America Immortalized Human Cells Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immortalized Human Cells Market Size (2020-2031)
7.2 Europe Immortalized Human Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Immortalized Human Cells Market Size by Country (2020-2025)
7.4 Europe Immortalized Human Cells Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Immortalized Human Cells Market Size (2020-2031)
8.2 Asia-Pacific Immortalized Human Cells Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Immortalized Human Cells Market Size by Region (2020-2025)
8.4 Asia-Pacific Immortalized Human Cells Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Immortalized Human Cells Market Size (2020-2031)
9.2 Latin America Immortalized Human Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Immortalized Human Cells Market Size by Country (2020-2025)
9.4 Latin America Immortalized Human Cells Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immortalized Human Cells Market Size (2020-2031)
10.2 Middle East & Africa Immortalized Human Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Immortalized Human Cells Market Size by Country (2020-2025)
10.4 Middle East & Africa Immortalized Human Cells Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ispecimen
11.1.1 Ispecimen Company Details
11.1.2 Ispecimen Business Overview
11.1.3 Ispecimen Immortalized Human Cells Introduction
11.1.4 Ispecimen Revenue in Immortalized Human Cells Business (2020-2025)
11.1.5 Ispecimen Recent Development
11.2 ABO Bio
11.2.1 ABO Bio Company Details
11.2.2 ABO Bio Business Overview
11.2.3 ABO Bio Immortalized Human Cells Introduction
11.2.4 ABO Bio Revenue in Immortalized Human Cells Business (2020-2025)
11.2.5 ABO Bio Recent Development
11.3 AnaBios
11.3.1 AnaBios Company Details
11.3.2 AnaBios Business Overview
11.3.3 AnaBios Immortalized Human Cells Introduction
11.3.4 AnaBios Revenue in Immortalized Human Cells Business (2020-2025)
11.3.5 AnaBios Recent Development
11.4 Biomedica Cro
11.4.1 Biomedica Cro Company Details
11.4.2 Biomedica Cro Business Overview
11.4.3 Biomedica Cro Immortalized Human Cells Introduction
11.4.4 Biomedica Cro Revenue in Immortalized Human Cells Business (2020-2025)
11.4.5 Biomedica Cro Recent Development
11.5 Bioivt
11.5.1 Bioivt Company Details
11.5.2 Bioivt Business Overview
11.5.3 Bioivt Immortalized Human Cells Introduction
11.5.4 Bioivt Revenue in Immortalized Human Cells Business (2020-2025)
11.5.5 Bioivt Recent Development
11.6 Iprocess
11.6.1 Iprocess Company Details
11.6.2 Iprocess Business Overview
11.6.3 Iprocess Immortalized Human Cells Introduction
11.6.4 Iprocess Revenue in Immortalized Human Cells Business (2020-2025)
11.6.5 Iprocess Recent Development
11.7 Crown Bioscience
11.7.1 Crown Bioscience Company Details
11.7.2 Crown Bioscience Business Overview
11.7.3 Crown Bioscience Immortalized Human Cells Introduction
11.7.4 Crown Bioscience Revenue in Immortalized Human Cells Business (2020-2025)
11.7.5 Crown Bioscience Recent Development
11.8 Biomex
11.8.1 Biomex Company Details
11.8.2 Biomex Business Overview
11.8.3 Biomex Immortalized Human Cells Introduction
11.8.4 Biomex Revenue in Immortalized Human Cells Business (2020-2025)
11.8.5 Biomex Recent Development
11.9 PrecisionMed
11.9.1 PrecisionMed Company Details
11.9.2 PrecisionMed Business Overview
11.9.3 PrecisionMed Immortalized Human Cells Introduction
11.9.4 PrecisionMed Revenue in Immortalized Human Cells Business (2020-2025)
11.9.5 PrecisionMed Recent Development
11.10 Cureline
11.10.1 Cureline Company Details
11.10.2 Cureline Business Overview
11.10.3 Cureline Immortalized Human Cells Introduction
11.10.4 Cureline Revenue in Immortalized Human Cells Business (2020-2025)
11.10.5 Cureline Recent Development
11.11 DX Biosamples
11.11.1 DX Biosamples Company Details
11.11.2 DX Biosamples Business Overview
11.11.3 DX Biosamples Immortalized Human Cells Introduction
11.11.4 DX Biosamples Revenue in Immortalized Human Cells Business (2020-2025)
11.11.5 DX Biosamples Recent Development
11.12 Audubon
11.12.1 Audubon Company Details
11.12.2 Audubon Business Overview
11.12.3 Audubon Immortalized Human Cells Introduction
11.12.4 Audubon Revenue in Immortalized Human Cells Business (2020-2025)
11.12.5 Audubon Recent Development
11.13 Precision for Medicine
11.13.1 Precision for Medicine Company Details
11.13.2 Precision for Medicine Business Overview
11.13.3 Precision for Medicine Immortalized Human Cells Introduction
11.13.4 Precision for Medicine Revenue in Immortalized Human Cells Business (2020-2025)
11.13.5 Precision for Medicine Recent Development
11.14 Discovery Life Sciences
11.14.1 Discovery Life Sciences Company Details
11.14.2 Discovery Life Sciences Business Overview
11.14.3 Discovery Life Sciences Immortalized Human Cells Introduction
11.14.4 Discovery Life Sciences Revenue in Immortalized Human Cells Business (2020-2025)
11.14.5 Discovery Life Sciences Recent Development
11.15 ProteoGenex
11.15.1 ProteoGenex Company Details
11.15.2 ProteoGenex Business Overview
11.15.3 ProteoGenex Immortalized Human Cells Introduction
11.15.4 ProteoGenex Revenue in Immortalized Human Cells Business (2020-2025)
11.15.5 ProteoGenex Recent Development
11.16 CGT Global
11.16.1 CGT Global Company Details
11.16.2 CGT Global Business Overview
11.16.3 CGT Global Immortalized Human Cells Introduction
11.16.4 CGT Global Revenue in Immortalized Human Cells Business (2020-2025)
11.16.5 CGT Global Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Immortalized Human Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Ready-to-use
Table 3. Key Players of Customized
Table 4. Global Immortalized Human Cells Market Size Growth Rate by Source (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Liver-Derived
Table 6. Key Players of Kidney-Derived
Table 7. Key Players of Nervous System-Derived
Table 8. Key Players of Other
Table 9. Global Immortalized Human Cells Market Size Growth Rate by Identity (US$ Million): 2020 VS 2024 VS 2031
Table 10. Key Players of Identified Samples
Table 11. Key Players of Anonymized Samples
Table 12. Global Immortalized Human Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 13. Global Immortalized Human Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 14. Global Immortalized Human Cells Market Size by Region (2020-2025) & (US$ Million)
Table 15. Global Immortalized Human Cells Market Share by Region (2020-2025)
Table 16. Global Immortalized Human Cells Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 17. Global Immortalized Human Cells Market Share by Region (2026-2031)
Table 18. Immortalized Human Cells Market Trends
Table 19. Immortalized Human Cells Market Drivers
Table 20. Immortalized Human Cells Market Challenges
Table 21. Immortalized Human Cells Market Restraints
Table 22. Global Immortalized Human Cells Revenue by Players (2020-2025) & (US$ Million)
Table 23. Global Immortalized Human Cells Market Share by Players (2020-2025)
Table 24. Global Top Immortalized Human Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immortalized Human Cells as of 2024)
Table 25. Ranking of Global Top Immortalized Human Cells Companies by Revenue (US$ Million) in 2024
Table 26. Global 5 Largest Players Market Share by Immortalized Human Cells Revenue (CR5 and HHI) & (2020-2025)
Table 27. Global Key Players of Immortalized Human Cells, Headquarters and Area Served
Table 28. Global Key Players of Immortalized Human Cells, Product and Application
Table 29. Global Key Players of Immortalized Human Cells, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Immortalized Human Cells Market Size by Type (2020-2025) & (US$ Million)
Table 32. Global Immortalized Human Cells Revenue Market Share by Type (2020-2025)
Table 33. Global Immortalized Human Cells Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 34. Global Immortalized Human Cells Revenue Market Share by Type (2026-2031)
Table 35. Global Immortalized Human Cells Market Size by Application (2020-2025) & (US$ Million)
Table 36. Global Immortalized Human Cells Revenue Market Share by Application (2020-2025)
Table 37. Global Immortalized Human Cells Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 38. Global Immortalized Human Cells Revenue Market Share by Application (2026-2031)
Table 39. North America Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. North America Immortalized Human Cells Market Size by Country (2020-2025) & (US$ Million)
Table 41. North America Immortalized Human Cells Market Size by Country (2026-2031) & (US$ Million)
Table 42. Europe Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Europe Immortalized Human Cells Market Size by Country (2020-2025) & (US$ Million)
Table 44. Europe Immortalized Human Cells Market Size by Country (2026-2031) & (US$ Million)
Table 45. Asia-Pacific Immortalized Human Cells Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 46. Asia-Pacific Immortalized Human Cells Market Size by Region (2020-2025) & (US$ Million)
Table 47. Asia-Pacific Immortalized Human Cells Market Size by Region (2026-2031) & (US$ Million)
Table 48. Latin America Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Latin America Immortalized Human Cells Market Size by Country (2020-2025) & (US$ Million)
Table 50. Latin America Immortalized Human Cells Market Size by Country (2026-2031) & (US$ Million)
Table 51. Middle East & Africa Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 52. Middle East & Africa Immortalized Human Cells Market Size by Country (2020-2025) & (US$ Million)
Table 53. Middle East & Africa Immortalized Human Cells Market Size by Country (2026-2031) & (US$ Million)
Table 54. Ispecimen Company Details
Table 55. Ispecimen Business Overview
Table 56. Ispecimen Immortalized Human Cells Product
Table 57. Ispecimen Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 58. Ispecimen Recent Development
Table 59. ABO Bio Company Details
Table 60. ABO Bio Business Overview
Table 61. ABO Bio Immortalized Human Cells Product
Table 62. ABO Bio Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 63. ABO Bio Recent Development
Table 64. AnaBios Company Details
Table 65. AnaBios Business Overview
Table 66. AnaBios Immortalized Human Cells Product
Table 67. AnaBios Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 68. AnaBios Recent Development
Table 69. Biomedica Cro Company Details
Table 70. Biomedica Cro Business Overview
Table 71. Biomedica Cro Immortalized Human Cells Product
Table 72. Biomedica Cro Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 73. Biomedica Cro Recent Development
Table 74. Bioivt Company Details
Table 75. Bioivt Business Overview
Table 76. Bioivt Immortalized Human Cells Product
Table 77. Bioivt Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 78. Bioivt Recent Development
Table 79. Iprocess Company Details
Table 80. Iprocess Business Overview
Table 81. Iprocess Immortalized Human Cells Product
Table 82. Iprocess Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 83. Iprocess Recent Development
Table 84. Crown Bioscience Company Details
Table 85. Crown Bioscience Business Overview
Table 86. Crown Bioscience Immortalized Human Cells Product
Table 87. Crown Bioscience Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 88. Crown Bioscience Recent Development
Table 89. Biomex Company Details
Table 90. Biomex Business Overview
Table 91. Biomex Immortalized Human Cells Product
Table 92. Biomex Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 93. Biomex Recent Development
Table 94. PrecisionMed Company Details
Table 95. PrecisionMed Business Overview
Table 96. PrecisionMed Immortalized Human Cells Product
Table 97. PrecisionMed Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 98. PrecisionMed Recent Development
Table 99. Cureline Company Details
Table 100. Cureline Business Overview
Table 101. Cureline Immortalized Human Cells Product
Table 102. Cureline Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 103. Cureline Recent Development
Table 104. DX Biosamples Company Details
Table 105. DX Biosamples Business Overview
Table 106. DX Biosamples Immortalized Human Cells Product
Table 107. DX Biosamples Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 108. DX Biosamples Recent Development
Table 109. Audubon Company Details
Table 110. Audubon Business Overview
Table 111. Audubon Immortalized Human Cells Product
Table 112. Audubon Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 113. Audubon Recent Development
Table 114. Precision for Medicine Company Details
Table 115. Precision for Medicine Business Overview
Table 116. Precision for Medicine Immortalized Human Cells Product
Table 117. Precision for Medicine Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 118. Precision for Medicine Recent Development
Table 119. Discovery Life Sciences Company Details
Table 120. Discovery Life Sciences Business Overview
Table 121. Discovery Life Sciences Immortalized Human Cells Product
Table 122. Discovery Life Sciences Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 123. Discovery Life Sciences Recent Development
Table 124. ProteoGenex Company Details
Table 125. ProteoGenex Business Overview
Table 126. ProteoGenex Immortalized Human Cells Product
Table 127. ProteoGenex Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 128. ProteoGenex Recent Development
Table 129. CGT Global Company Details
Table 130. CGT Global Business Overview
Table 131. CGT Global Immortalized Human Cells Product
Table 132. CGT Global Revenue in Immortalized Human Cells Business (2020-2025) & (US$ Million)
Table 133. CGT Global Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
Table 137. Authors List of This Report
List of Figures
Figure 1. Immortalized Human Cells Picture
Figure 2. Global Immortalized Human Cells Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Immortalized Human Cells Market Share by Type: 2024 VS 2031
Figure 4. Ready-to-use Features
Figure 5. Customized Features
Figure 6. Global Immortalized Human Cells Market Size Comparison by Source (2020-2031) & (US$ Million)
Figure 7. Liver-Derived Features
Figure 8. Kidney-Derived Features
Figure 9. Nervous System-Derived Features
Figure 10. Other Features
Figure 11. Global Immortalized Human Cells Market Size Comparison by Identity (2020-2031) & (US$ Million)
Figure 12. Identified Samples Features
Figure 13. Anonymized Samples Features
Figure 14. Global Immortalized Human Cells Market Size by Application (2020-2031) & (US$ Million)
Figure 15. Global Immortalized Human Cells Market Share by Application: 2024 VS 2031
Figure 16. Medical Research Case Studies
Figure 17. Vaccine Development Case Studies
Figure 18. Gene Therapy Case Studies
Figure 19. Other Case Studies
Figure 20. Immortalized Human Cells Report Years Considered
Figure 21. Global Immortalized Human Cells Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 22. Global Immortalized Human Cells Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 23. Global Immortalized Human Cells Market Share by Region: 2024 VS 2031
Figure 24. Global Immortalized Human Cells Market Share by Players in 2024
Figure 25. Global Immortalized Human Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. The Top 10 and 5 Players Market Share by Immortalized Human Cells Revenue in 2024
Figure 27. North America Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. North America Immortalized Human Cells Market Share by Country (2020-2031)
Figure 29. United States Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Canada Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Immortalized Human Cells Market Share by Country (2020-2031)
Figure 33. Germany Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. France Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. U.K. Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Italy Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Russia Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Ireland Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Immortalized Human Cells Market Share by Region (2020-2031)
Figure 41. China Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Japan Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. South Korea Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. India Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Australia & New Zealand Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Immortalized Human Cells Market Share by Country (2020-2031)
Figure 49. Mexico Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Brazil Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Immortalized Human Cells Market Share by Country (2020-2031)
Figure 53. Israel Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. UAE Immortalized Human Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Ispecimen Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 57. ABO Bio Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 58. AnaBios Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 59. Biomedica Cro Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 60. Bioivt Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 61. Iprocess Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 62. Crown Bioscience Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 63. Biomex Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 64. PrecisionMed Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 65. Cureline Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 66. DX Biosamples Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 67. Audubon Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 68. Precision for Medicine Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 69. Discovery Life Sciences Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 70. ProteoGenex Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 71. CGT Global Revenue Growth Rate in Immortalized Human Cells Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
